Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Clonazepam · 1 trial · 1 indication
Summary of video EEG number of spikes and sharp waves. Over a 24 hour period.
| Arm | Type | Description |
|---|---|---|
| Intranasal Clonazepam 2 mg | EXPERIMENTAL | - |
| Intranasal Clonazepam 3 mg | EXPERIMENTAL | - |
| Intranasal Clonazepam both Dose Groups 2 mg & 3 mg | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Clonazepam | DRUG | 1 Dose |
Inclusion Criteria: * Diagnosis of refractory epilepsy * No Nasal conditions that would preclude the use of intranasal product Exclusion Criteria: * Subject with a clinical significant unstable medical abnormality * Subject currently or regularly taking Clonazepam